Register for an account

X

Enter your name and email address below.

Your email address is used to log in and will not be shared or sold. Read our privacy policy.

X

Website access code

Enter your access code into the form field below.

If you are a Zinio, Nook, Kindle, Apple, or Google Play subscriber, you can enter your website access code to gain subscriber access. Your website access code is located in the upper right corner of the Table of Contents page of your digital edition.

The Sciences

Ben Goldacre on more bad data: this time from drug companies

The LoomBy Carl ZimmerSeptember 30, 2012 7:47 PM

Newsletter

Sign up for our email newsletter for the latest science news

This morning I was accused of writing "corporate sponsored blogs whoring themselves out to all and sundry." Actually, I was arguing that science writers have a duty to call out weak science and press manipulation rather than cave into it. That applies to any kind of research. I happened to be talking about research on genetically modified foods and their health risks. But it applies just as well to pharmaceutical corporations that deep-six drug trials that don't support their drugs. The most eloquent critic of this bad behavior is Ben Goldacre. You can watch this video of a TED talk he recently gave on the subject, read this essay in the Guardian, or pre-order his new book, Bad Pharma. If highlighting Goldacre's vital work means I have to return my gold-plated corporate-whore Corvette, so be it. [Update: Guardian link fixed, book title fixed]

    2 Free Articles Left

    Want it all? Get unlimited access when you subscribe.

    Subscribe

    Already a subscriber? Register or Log In

    Want unlimited access?

    Subscribe today and save 70%

    Subscribe

    Already a subscriber? Register or Log In